Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain

Nature Biotechnology
Benjamin E DevermanViviana Gradinaru

Abstract

Recombinant adeno-associated viruses (rAAVs) are commonly used vehicles for in vivo gene transfer. However, the tropism repertoire of naturally occurring AAVs is limited, prompting a search for novel AAV capsids with desired characteristics. Here we describe a capsid selection method, called Cre recombination-based AAV targeted evolution (CREATE), that enables the development of AAV capsids that more efficiently transduce defined Cre-expressing cell populations in vivo. We use CREATE to generate AAV variants that efficiently and widely transduce the adult mouse central nervous system (CNS) after intravenous injection. One variant, AAV-PHP.B, transfers genes throughout the CNS with an efficiency that is at least 40-fold greater than that of the current standard, AAV9 (refs. 14,15,16,17), and transduces the majority of astrocytes and neurons across multiple CNS regions. In vitro, it transduces human neurons and astrocytes more efficiently than does AAV9, demonstrating the potential of CREATE to produce customized AAV vectors for biomedical applications.

References

Jul 1, 1989·Genes & Development·N LevittN J Proudfoot
Apr 1, 1995·The Plant Journal : for Cell and Molecular Biology·H AlbertD W Ow
Jun 13, 1998·Human Gene Therapy·J S BartlettT J McCown
Jan 9, 1999·Journal of Virology·J A ChioriniR M Kotin
Oct 21, 2004·Nature Neuroscience·A Denise R GarciaMichael V Sofroniew
Jan 24, 2006·Nature Biotechnology·Narendra MaheshriDavid V Schaffer
Jul 11, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhijian WuR Jude Samulski
Apr 29, 2008·The New England Journal of Medicine·Albert M MaguireJean Bennett
Dec 23, 2008·Nature Biotechnology·Kevin D FoustBrian K Kaspar
Jan 13, 2009·The Journal of Infectious Diseases·Roberto CalcedoJames M Wilson
Feb 25, 2009·Proceedings of the National Academy of Sciences of the United States of America·Katherine J D A ExcoffonDavid V Schaffer
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Florian SonntagJürgen A Kleinschmidt
Dec 1, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nicholas R WallEdward M Callaway
Dec 24, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jun XieGuangping Gao
Jan 20, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Amit C NathwaniAndrew M Davidoff
Feb 16, 2011·Human Gene Therapy·J Nicholas Betley, Scott M Sternson
Mar 3, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nagesh PulicherlaAravind Asokan
Apr 14, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Steven J GrayR Jude Samulski
Aug 4, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adam K BevanBrian K Kaspar
Oct 6, 2011·Current Protocols in Neuroscience·Steven J GrayRichard Jude Samulski
Dec 29, 2011·Human Gene Therapy·Lluis SamaranchKrystof S Bankiewicz
Dec 20, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Florie BorelChristian Mueller
Jan 7, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Brett D DufourJodi L McBride
Feb 22, 2014·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·David S OjalaDavid V Schaffer
Apr 26, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·K H HighD Lillicrap
Aug 28, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Casey A MaguireXandra O Breakefield
May 8, 2015·Neuron·Juan Carlos Izpisua BelmonteFeng Zhang

❮ Previous
Next ❯

Citations

Mar 29, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jakob KörbelinMartin Trepel
Apr 28, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sourav R ChoudhuryMiguel Sena-Esteves
Jul 26, 2016·Frontiers in Synaptic Neuroscience·Hojin LeeJinhyun Kim
Jun 9, 2016·Human Gene Therapy·Michaël HocquemillerNathalie Cartier
Aug 18, 2016·Frontiers in Molecular Neuroscience·Lorelei Stoica, Miguel Sena-Esteves
Sep 26, 2016·Histochemistry and Cell Biology·Roeland Buckinx, Jean-Pierre Timmermans
Dec 21, 2016·Scientific Reports·Cristina FimianiAntonello Mallamaci
Jan 12, 2017·Human Gene Therapy·Paul N Valdmanis, Mark A Kay
Nov 15, 2016·Scientific Reports·Yi-Ying ChouTom Kirchhausen
Mar 18, 2017·Nature Reviews. Neuroscience·Christina K KimKarl Deisseroth
Jun 3, 2017·Health Security·Diane DiEuliis, James Giordano
Feb 26, 2016·Neuropharmacology·Sourav R ChoudhuryPaola Grandi
Jan 11, 2017·Brain Research Bulletin·Anton DvorzhakRosemarie Grantyn
Dec 13, 2016·BioTechniques·Sarah Webb
Jan 29, 2017·Journal of Neural Transmission·D PignataroJosé L Lanciego
Feb 6, 2017·Fluids and Barriers of the CNS·Richard F KeepLester R Drewes
Jul 27, 2017·Nature Neuroscience·Keisuke Yonehara, Botond Roska
Feb 2, 2018·Autophagy·Vicente ValenzuelaClaudio Hetz
Oct 28, 2017·Science·Viviana Gradinaru
Jun 4, 2016·Molecular Biology of the Cell·James Shorter
May 25, 2018·Annual Review of Biophysics·Viviana GradinaruKarl Deisseroth
Dec 26, 2017·Frontiers in Neural Circuits·Philippe SaltielEmilio Bizzi
Jan 10, 2018·Frontiers in Oncology·David WasilewskiManuel Valiente
May 2, 2018·Annual Review of Neuroscience·Claire N BedbrookViviana Gradinaru
Mar 8, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mychal S GramesRonald L Klein
Aug 25, 2017·Human Gene Therapy·Dirk Grimm, Hildegard Büning
May 31, 2017·Human Gene Therapy·Francesco Albert Bosco CorteseGiovanni Santostasi
Oct 17, 2017·Human Gene Therapy·Françoise PiguetNathalie Cartier
Aug 11, 2018·Nature Reviews. Drug Discovery·Benjamin E DevermanDinah W Y Sah
Oct 4, 2018·Physiological Reviews·Melanie D SweeneyBerislav V Zlokovic
Dec 28, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Fabio BlandiniJosé L Lanciego
Jan 26, 2018·Annals of Neurology·Eleonora CavalcaAlessandra Biffi
Dec 14, 2017·Nature·Gabriel L ButterfieldDavid Baker
Aug 30, 2016·Nature Neuroscience·Charles G JenningsGuoping Feng
Mar 23, 2019·Current Protocols in Neuroscience·Shih-Heng ChenNegin P Martin
Mar 1, 2019·British Journal of Pharmacology·Lars M IttnerYazi D Ke
Dec 19, 2017·Nature Biotechnology·Rajib SchubertBotond Roska

❮ Previous
Next ❯

Datasets Mentioned

BETA
AF085716.1
41

Methods Mentioned

BETA
PCR
transgenic
transfect
transfection
Rep-Cap
enzymatic dissociation

Software Mentioned

CREATE
Bitplane
Imaris

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Researcher Network:CZI Neurodegeneration Challenge

The Neurodegeneration Challenge Network aims to provide funding for and to bring together researchers studying neurodegenerative diseases. Find the latest research from the NDCN grantees here.